Clinical Trial

Digital Screening for Atrial Fibrillation to Prevent Stroke

Study acronym: ADHP
Recruiting
View on ClinicalTrials.gov →
Summary
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.
Trial Details
NCT Number NCT07684053
Lead Sponsor Medical University Innsbruck
Collaborators: AIT Austrian Institute of Technology GmbH, Medical University of Graz, UMIT Tirol
Conditions Atrial Fibrillation (Prevention of Stroke), Stroke
Enrollment 100,060 participants
Start Date 2026-06-29
Primary Completion 2031-12-31 (estimated)
Study Completion 2032-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-06